Inverting hydrolases and their use in enantioconvergent biotransformations

Trends in Biotechnology

Volumn 31, Issue 8, 2013, Pages 468-478

  Schober, Markus ^a   Faber, Kurt ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Dehalogenase; Deracemization; Enantioconvergent process; Epoxide hydrolase; Inversion; Retention; Sulfatase

Indexed keywords

DE-RACEMIZATION; DEHALOGENASE; EPOXIDE HYDROLASES; INVERSION; RETENTION; SULFATASES;

CELL IMMOBILIZATION;

HYDROLASES;

ALCOHOL DERIVATIVE; ALKANE DERIVATIVE; AMINE; AMINO ACID; ARYLSULFATASE; CARBONYL DERIVATIVE; CARBOXYLIC ACID; EPICHLOROHYDRIN; EPOXIDE HYDROLASE; HALOACID; HALOALCOHOL; HALOALKANE DEHALOGENASE; HYDROLASE; SULFATASE; UNCLASSIFIED DRUG;

BIOREMEDIATION; BIOTRANSFORMATION; CATALYSIS; COVALENT BOND; ENANTIOMER; ENZYME KINETICS; ENZYME STRUCTURE; ENZYME SUBSTRATE; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; RACEMIC MIXTURE; REVIEW; STEREOCHEMISTRY; THERMOSTABILITY;

DEHALOGENASE; DERACEMIZATION; ENANTIOCONVERGENT PROCESS; EPOXIDE HYDROLASE; INVERSION; RETENTION; SULFATASE;

BIOTECHNOLOGY; BIOTRANSFORMATION; HYDROLASES; STEREOISOMERISM;

EID: 84880513684     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2013.05.005     Document Type: Review

References (98)

1. Hudlicky T., Reed J.W. Applications of biotransformations and biocatalysis to complexity generation in organic synthesis. Chem. Soc. Rev. 2009, 38:3117-3132.
2. Patel R.N. Biocatalysis: Synthesis of key intermediates for development of pharmaceuticals. ACS Catal. 2011, 1:1056-1074.
3. Pollard D.J., Woodley J.M. Biocatalysis for pharmaceutical intermediates: the future is now. Trends Biotechnol. 2007, 25:66-73.
4. Schrittwieser J.H., et al. Biocatalytic enantioselective oxidative C-C coupling by aerobic C-H activation. Angew. Chem. Int. Ed. 2011, 50:1068-1071.
5. Woodley J.M. New opportunities for biocatalysis: making pharmaceutical processes greener. Trends Biotechnol. 2008, 26:321-327.
6. Hall M., Bommarius A.S. Enantioenriched compounds via enzyme-catalyzed redox reactions. Chem. Rev. 2011, 111:4088-4110.
7. Matsuda T., et al. Recent progress in biocatalysis for asymmetric oxidation and reduction. Tetrahedron: Asymmetry 2009, 20:513-557.
8. Hoyos P., et al. Dynamic kinetic resolution via hydrolase-metal combo catalysis in stereoselective synthesis of bioactive compounds. Adv. Synth. Catal. 2012, 354:2585-2611.
9. Turner N.J. Deracemisation methods. Curr. Opin. Chem. Biol. 2010, 14:115-121.
10. Pamies O., Backvall J.E. Combination of enzymes and metal catalysts. A powerful approach in asymmetric catalysis. Chem. Rev. 2003, 103:3247-3261.
11. Gruber C.C., et al. From a racemate to a single enantiomer: deracemization by stereoinversion. Adv. Synth. Catal. 2006, 348:1789-1805.
12. Schrittwieser J.H., et al. Recent biocatalytic oxidation-reduction cascades. Curr. Opin. Chem. Biol. 2011, 15:249-256.
13. Voss C.V., et al. Orchestration of concurrent oxidation and reduction cycles for stereoinversion and deracemisation of sec-alcohols. J. Am. Chem. Soc. 2008, 130:13969-13972.
14. Duhamel L., et al. Enantioselective protonations: fundamental insights and new concepts. Tetrahedron: Asymmetry 2004, 15:3653-3691.
15. Monterde M.I., et al. Enzymatic transformations. Part 58: enantioconvergent biohydrolysis of styrene oxide derivatives catalysed by the Solanum tuberosum epoxide hydrolase. Tetrahedron: Asymmetry 2004, 15:2801-2805.
16. Schober M., et al. One-pot deracemization of sec-alcohols: enantioconvergent enzymatic hydrolysis of alkyl sulfates using stereocomplementary sulfatases. Angew. Chem. Int. Ed. 2013, 52:3277-3279.
17. Schober M., et al. A stereoselective inverting sec-alkylsulfatase for the deracemization of sec-alcohols. Org. Lett. 2011, 13:4296-4299.
18. Simeo Y., Faber K. Selectivity enhancement of enantio- and stereo-complementary epoxide hydrolases and chemo-enzymatic deracemization of (±)-2-methylglycidyl benzyl ether. Tetrahedron: Asymmetry 2006, 17:402-409.
19. Szymanski W., et al. A simple enantioconvergent and chemo-enzymatic synthesis of optically active α-substituted amides. Angew. Chem. Int. Ed. 2011, 50:10712-10715.
20. Ito H., et al. Direct enantio-convergent transformation of racemic substrates without racemization or symmetrization. Nat. Chem. 2010, 2:972-976.
21. Kroutil W., et al. Deracemization of (±)-cis-2,3-epoxyheptane via enantioconvergent biocatalytic hydrolysis using Nocardia EH1-epoxide hydrolase. Tetrahedron Lett. 1996, 37:8379-8382.
22. Kroutil W., et al. Deracemization of (±)-2,3-disubstituted oxiranes via biocatalytic hydrolysis using epoxide hydrolases: Kinetics of an enantioconvergent process. J. Chem. Soc., Perkin Trans. 1 1997, 3629-3636.
23. Steinreiber A., et al. Biocatalytic asymmetric and enantioconvergent hydrolysis of trisubstituted oxiranes. Tetrahedron: Asymmetry 2001, 12:1519-1528.
24. Hwang S., et al. Enantioconvergent bioconversion of p-chlorostyrene oxide to (R)-p-chlorophenyl-1,2-ethanediol by the bacterial epoxide hydrolase of Caulobacter crescentus. Biotechnol. Lett. 2008, 30:1219-1225.
25. Hwang S., et al. One-pot biotransformation of racemic styrene oxide into (R)-1,2-phenylethanediol by two recombinant microbial epoxide hydrolases. Biotechnol. Bioprocess Eng. 2008, 13:453-457.
26. Kim H.S., et al. Biosynthesis of (R)-phenyl-1,2-ethanediol from racemic styrene oxide by using bacterial and marine fish epoxide hydrolases. Biotechnol. Lett. 2008, 30:127-133.
27. Pedragosa-Moreau S., et al. Microbiological transformations. 28. Enantiocomplementary epoxide hydrolyses as a preparative access to both enantiomers of styrene oxide. J. Org. Chem. 1993, 58:5533-5536.
28. Danda H., et al. Preparation of optically active secondary alcohols by combination of enzymatic hydrolysis and chemical transformation. Tetrahedron 1991, 47:8701-8716.
29. Szymanski W., Ostaszewski R. Multicomponent diversity and enzymatic enantioselectivity as a route towards both enantiomers of α-amino acids - a model study. Tetrahedron: Asymmetry 2006, 17:2667-2671.
30. Mitsuda S., et al. Preparation of an optically pure secondary alcohol of synthetic pyrethroids using microbial lipases. Appl. Microbiol. Biotechnol. 1988, 29:310-315.
31. Danda H., et al. Preparation of (4S)-4-hydroxy-3-methyl-2-(2'-propynyl)-2-cyclopentenone by combination of enzymatic hydrolysis and chemical transformation. Tetrahedron Lett. 1991, 32:5119-5122.
32. Steinreiber J., et al. De-racemization of enantiomers versus de-epimerization of diastereomers: classification of novel types of DYKAT. Chem. Eur. J. 2008, 14:8060-8072.
33. Hanson S.R., et al. Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew. Chem. Int. Ed. 2004, 43:5736-5763.
34. Gadler P., Faber K. New enzymes for biotransformations: microbial alkyl sulfatases displaying stereo- and enantioselectivity. Trends Biotechnol. 2007, 25:83-88.
35. Pogorevc M., et al. Enantioselective stereoinversion in the kinetic resolution of rac-sec-alkyl sulfate esters by hydrolysis with an alkylsulfatase from Rhodococcus ruber DSM 44541 furnishes homochiral products. Angew. Chem. Int. Ed. 2002, 41:4052-4054.
36. Hagelueken G., et al. The crystal structure of SdsA1, an alkylsulfatase from Pseudomonas aeruginosa, defines a third class of sulfatases. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7631-7636.
37. Müller I., et al. Crystal structure of the alkylsulfatase AtsK: insights into the catalytic mechanism of the Fe(II) α-ketoglutarate-dependent dioxygenase superfamily. Biochemistry 2004, 43:3075-3088.
38. Gadler P., Faber K. Highly enantioselective biohydrolysis of sec-alkyl sulfate esters with inversion of configuration catalysed by Pseudomonas spp. Eur. J. Org. Chem. 2007, 2007:5527-5530.
39. Wallner S.R., et al. Highly enantioselective sec-alkyl sulfatase activity of the marine planctomycete Rhodopirellula baltica shows retention of configuration. Angew. Chem. Int. Ed. 2005, 44:6381-6384.
40. Knaus T., et al. Structure and mechanism of an inverting alkylsulfatase from Pseudomonas sp DSM6611 specific for secondary alkyl sulfates. FEBS J. 2012, 279:4374-4384.
41. Schober M., et al. The substrate spectrum of the inverting sec-alkylsulfatase Pisa1. Adv. Synth. Catal. 2012, 354:1737-1742.
42. Fuchs M., et al. Chemo-enzymatic asymmetric total synthesis of (R)-lasiodiplodin methyl ether through a sulfatase-based deracemization process. Eur. J. Org. Chem. 2013, 356-361.
43. Kotik M., et al. Epoxide hydrolases and their application in organic synthesis. Curr. Org. Chem. 2012, 16:451-482.
44. Nardini M., et al. The X-ray structure of epoxide hydrolase from Agrobacterium radiobacter AD1 - an enzyme to detoxify harmful epoxides. J. Biol. Chem. 1999, 274:14579-14586.
45. Arand M., et al. Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active site. EMBO J. 2003, 22:2583-2592.
46. Widersten M., et al. Structure-function relationships of epoxide hydrolases and their potential use in biocatalysis. Biochim. Biophys. Acta 2010, 1800:316-326.
47. Kotik M., et al. Access to enantiopure aromatic epoxides and diols using epoxide hydrolases derived from total biofilter DNA. J. Mol. Catal. B: Enzymatic 2010, 65:41-48.
48. Reetz M.T., et al. Directed evolution of an enantioselective epoxide hydrolase: uncovering the source of enantioselectivity at each evolutionary stage. J. Am. Chem. Soc. 2009, 131:7334-7343.
49. Zheng H., et al. Directed evolution of enantioconvergency: the case of an epoxide hydrolase-catalyzed reaction of a racemic epoxide. ChemCatChem 2010, 2:958-961.
50. Zheng H., Reetz M.T. Manipulating the stereoselectivity of limonene epoxide hydrolase by directed evolution based on iterative saturation mutagenesis. J. Am. Chem. Soc. 2010, 132:15744-15751.
51. Gurell A., Widersten M. Modification of substrate specificity resulting in an epoxide hydrolase with shifted enantiopreference for (2,3-epoxypropyl)benzene. ChemBioChem 2010, 11:1422-1429.
52. Carlsson A.J., et al. Obtaining optical purity for product diols in enzyme-catalyzed epoxide hydrolysis: Contributions from changes in both enantio- and regioselectivity. Biochemistry 2012, 51:7627-7637.
53. Kotik M., et al. Cloning of an epoxide hydrolase-encoding gene from Aspergillus niger M200, overexpression in E. coli, and modification of activity and enantioselectivity of the enzyme by protein engineering. J. Biotechnol. 2007, 132:8-15.
54. van Loo B., et al. Improved enantioselective conversion of styrene epoxides and meso-epoxides through epoxide hydrolases with a mutated nucleophile-flanking residue. Enzyme Microb. Technol. 2009, 44:145-153.
55. Lin S., et al. Characterization of the epoxide hydrolase NcsF2 from the neocarzinostatin biosynthetic gene cluster. Org. Lett. 2010, 12:3816-3819.
56. Fetzner S. Bacterial dehalogenation. Appl. Microbiol. Biotechnol. 1998, 50:633-657.
57. Janssen D.B. Biocatalysis by dehalogenating enzymes. Advances in Applied Microbiology 2007, 233-252. Academic Press. I. Allen (Ed.).
58. Kurihara T. A mechanistic analysis of enzymatic degradation of organohalogen compounds. Biosci. Biotechnol. Biochem. 2011, 75:189-198.
59. Hill K.E., et al. Investigation of two evolutionarily unrelated halocarboxylic acid dehalogenase gene families. J. Bacteriol. 1999, 181:2535-2547.
60. Slater J.H., et al. Microbial dehalogenation. Biodegradation 1995, 6:181-189.
61. Soda K., et al. Bacterial 2-haloacid dehalogenases: structures and catalytic properties. Pure Appl. Chem. 1996, 68:2097-2103.
62. Arai R., et al. Crystal structure of the probable haloacid dehalogenase PH0459 from Pyrococcus horikoshii OT3. Protein Sci. 2006, 15:373-377.
63. Hisano T., et al. Crystal structure of L-2-haloacid dehalogenase from Pseudomonas sp YL - An α/β-hydrolase structure that is different from the α/β-hydrolase fold. J. Biol. Chem. 1996, 271:20322-20330.
64. Ridder I.S., et al. Three-dimensional structure of L-2-haloacid dehalogenase from Xanthobacter autotrophicus GJ10 complexed with the substrate-analogue formate. J. Biol. Chem. 1997, 272:33015-33022.
65. Rye C.A., et al. Biochemical and structural studies of an L-haloacid dehalogenase from the thermophilic archaeon Sulfolobus tokodaii. Extremophiles 2009, 13:179-190.
66. Schmidberger J.W., et al. The crystal structure of Dehl reveals a new α-haloacid dehalogenase fold and active-site mechanism. J. Mol. Biol. 2008, 378:284-294.
67. 18O incorporation experiments. J. Biol. Chem. 1995, 270:18309-18312.
68. Kurihara T., et al. Comprehensive site-directed mutagenesis of L-2-haloacid dehalogenase to probe catalytic amino acid residues. J. Biochem. 1995, 117:1317-1322.
69. Hamid T.H.T.A., et al. A review on non-stereospecific haloalkanoic acid dehalogenases. Afr. J. Biotechnol. 2011, 10:9725-9736.
70. Asano Y., Hölsch K. Isomerizations. Enzyme Catalysis in Organic Synthesis 2012, 1607-1684. Wiley-VCH. K.H. Drauz (Ed.).
71. Nardi-Dei V., et al. DL-2-haloacid dehalogenase from Pseudomonas sp 113 is a new class of dehalogenase catalyzing hydrolytic dehalogenation not involving enzyme-substrate ester intermediate. J. Biol. Chem. 1999, 274:20977-20981.
72. Park C., et al. A new DL-2-haloacid dehalogenase acting on 2-haloacid amides: purification, characterization, and mechanism. J. Mol. Catal. B: Enzymatic 2003, 23:329-336.
73. Kurihara T., et al. Bacterial 2-haloacid dehalogenases: structures and reaction mechanisms. J. Mol. Catal. B: Enzymatic 2000, 10:57-65.
74. Sudi I.Y., et al. Structure prediction, molecular dynamics simulation and docking studies of D-specific dehalogenase from Rhizobium sp RC1. Int. J. Mol. Sci. 2012, 13:15724-15754.
75. Huyop F., Sudi I.Y. D-Specific dehalogenases, a review. Biotechnol. Biotechnol. Equip. 2012, 26:2817-2822.
76. Weightman A.J., et al. Stereospecificity of 2-monochloropropionate dehalogenation by the two dehalogenases of Pseudomonas putida PP3: evidence for two different dehalogenation mechanisms. J. Gen. Microbiol. 1982, 128:1755-1762.
77. Motosugi K., et al. Enzymatic preparation of D- and L-lactic acid from racemic 2-chloropropionic acid. Biotechnol. Bioeng. 1984, 26:805-806.
78. Taylor S.C. (S)-2-chloropanoic acid: developments in its industrial manufacture. Chirality in Industry 1997, Vol. 2:207-223. Wiley.
79. Hasan A.K.M.Q., et al. Total conversion of racemic 2-chloropropionic acid into D-lactate by combination of enzymatic and chemical dehalogenations. J. Ferment. Bioeng. 1991, 72:481-482.
80. Hasan A.K.M.Q., et al. Catalytic action of L-2-halo acid dehalogenase on long-chain L-2-haloalkanoic acids in organic solvents. Biotechnol. Bioeng. 1991, 38:1114-1117.
81. Koudelakova T., et al. Haloalkane dehalogenases: biotechnological applications. Biotechnol. J. 2013, 8:32-45.
82. Chan W.Y., et al. Sequence- and activity-based screening of microbial genomes for novel dehalogenases. Microb. Biotechnol. 2010, 3:107-120.
83. Chovancova E., et al. Phylogenetic analysis of haloalkane dehalogenases. Proteins: Struct. Funct. Bioinform. 2007, 67:305-316.
84. Koudelakova T., et al. Substrate specificity of haloalkane dehalogenases. Biochem. J. 2011, 435:345-354.
85. Hasan K., et al. Biochemical characteristics of the novel haloalkane dehalogenase DatA, isolated from the plant pathogen Agrobacterium tumefaciens C58. Appl. Environ. Microbiol. 2011, 77:1881-1884.
86. Prokop Z., et al. Enantioselectivity of haloalkane dehalogenases and its modulation by surface loop engineering. Angew. Chem. Int. Ed. 2010, 49:6111-6115.
87. Chaloupkova R., et al. Stereoselectivity and conformational stability of haloalkane dehalogenase DbjA from Bradyrhizobium japonicum USDA110: the effect of pH and temperature. FEBS J. 2011, 278:2728-2738.
88. Koudelakova T., et al. Engineering enzyme stability and resistance to an organic cosolvent by modification of residues in the access tunnel. Angew. Chem. Int. Ed. 2013, 52:1959-1963.
89. Pavlova M., et al. Redesigning dehalogenase access tunnels as a strategy for degrading an anthropogenic substrate. Nat. Chem. Biol. 2009, 5:727-733.
90. Kasai N., Suzuki T. Industrialization of the microbial resolution of chiral C3 and C4 synthetic units: from a small beginning to a major operation, a personal account. Adv. Synth. Catal. 2003, 345:437-455.
91. van Leeuwen J.G.E., et al. Directed evolution strategies for enantiocomplementary haloalkane dehalogenases: from chemical waste to enantiopure building blocks. ChemBioChem 2012, 13:137-148.
92. Westerbeek A., et al. Haloalkane dehalogenase catalysed desymmetrisation and tandem kinetic resolution for the preparation of chiral haloalcohols. Tetrahedron 2012, 68:7645-7650.
93. Westerbeek A., et al. Kinetic resolution of α-bromoamides: experimental and theoretical investigation of highly enantioselective reactions catalyzed by haloalkane dehalogenases. Adv. Synth. Catal. 2011, 353:931-944.
94. Westerbeek A., et al. Dynamic kinetic resolution process employing haloalkane dehalogenase. ACS Catal. 2011, 1:1654-1660.
95. Heeb N.V., et al. Stereochemistry of LinB-catalyzed biotransformation of δ-HBCD to 1R,2R,5S,6R,9R,10S-pentabromocyclododecanol. Chemosphere 2013, 90:1911-1919.
96. Janssen D.B., et al. Bacterial degradation of xenobiotic compounds: evolution and distribution of novel enzyme activities. Environ. Microbiol. 2005, 7:1868-1882.
97. Orru R.V.A., et al. Chemo-enzymatic deracemization of (±)-2,2-disubstituted oxiranes. Tetrahedron 1998, 54:859-874.
98. Drienovska I., et al. Biochemical characterization of a novel haloalkane dehalogenase from a cold-adapted bacterium. Appl. Environ. Microbiol. 2012, 78:4995-4998.